Lehrstuhl für Physiologie

Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy (2026) Dugas-Breit S, Forschner A, Erdmann M, Gutzmer R, Kähler KC, Holst I, Brekner A, et al. Journal article Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis (2026) Geidel G, Bänsch S, Adam L, Fekade N, Rünger A, Zell T, Smit DJ, et al. Journal article Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM) (2025) Kalkavan H, Scheulen ME, Kämpgen E, Keilholz U, Heinzerling L, Lueong SS, Hlinka A, et al. Journal article Preanalytical stability of plasma calcitonin gene–related peptide: clinical and research implications (2025) Frank F, Eller MT, Maier S, Janisch L, Labrecque S, Kaltseis K, Meßlinger K, et al. Journal article Histamine plasma levels from dietary histidine/histamine intake correlate with CGRP in trigeminal tissues (2025) de Mora F, Dux M, Vogler B, Kuhn A, Schramm J, Meßlinger K Journal article Gene expression and molecular pathway analyses differentiate immunotherapy-induced myositis from spontaneous dermatomyositis (2025) Röckel M, Musella L, Preusse C, Radke J, Zimmer L, Thoms KM, Dimitriou F, et al. Journal article Substance P release from rat dura mater is inversely correlated with CGRP release– experiments using glycerol trinitrate and anti-CGRP antibodies (2025) Dux M, Meßlinger K Journal article Association of HLA-A*02:01 type with efficacy and toxicity of immune checkpoint inhibitor therapy in melanoma patients: a retrospective cohort study (2025) Manger I, Schmitt C, Berking C, French LE, Vera González J, Heinzerling L Journal article International real-world study of combination immunotherapy sequences in metastatic melanoma. (2025) Guardamagna M, Lochrin SE, Smithy JW, Postow M, Gaudy-Marqueste C, Malissen N, Monestier S, et al. Journal article Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8 (2025) Koch E, Liguori R, Castro AA, Schliep S, Petzold A, Wessely A, Fröhlich W, et al. Journal article